Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitroglycerin intravenous infusion.

G T Elliott, S L Quinn

    Drug Intelligence & Clinical Pharmacy
    |March 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Intravenous nitroglycerin is commonly used for cardiovascular issues like heart failure and hypertension, despite lacking FDA approval. This review covers its applications and hospital preparation methods for this unapproved but popular treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tyrosine kinase signaling in action potential shortening and expression of HSP72 in late preconditioning.

    American journal of physiology. Heart and circulatory physiology·2000
    Same author

    Preconditioning of swine heart with monophosphoryl lipid A improves myocardial preservation.

    The Annals of thoracic surgery·2000
    Same author

    The novel glycolipid RC-552 attenuates myocardial stunning and reduces infarct size in dogs.

    Journal of molecular and cellular cardiology·2000
    Same author

    Monophosphoryl lipid A: a novel nitric oxide-mediated therapy to attenuate platelet thrombosis?

    Journal of cardiovascular pharmacology·2000
    Same author

    Cellular mechanisms of infarct size reduction with ischemic preconditioning. Role of calcium?

    Annals of the New York Academy of Sciences·1999
    Same author

    Pharmacologic enhancement of tolerance to ischemic cardiac stress using monophosphoryl lipid A. A comparison with antecedent ischemia.

    Annals of the New York Academy of Sciences·1999
    Same journal

    Profile of prescription medication in a pediatric population.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    SI units in drug therapeutics.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Physicians' review of significant interventions by clinical pharmacists in inpatient care.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Possible interaction of ranitidine with phenytoin.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Famotidine-associated mental confusion in elderly patients.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

    Drug intelligence & clinical pharmacy·1988
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Intravenous nitroglycerin is frequently used for cardiovascular conditions.
    • Its use is widespread despite lacking FDA approval for commercial use.

    Purpose of the Study:

    • To review the established and potential clinical applications of intravenous nitroglycerin.
    • To discuss the advantages and disadvantages of extemporaneous preparation and storage techniques for intravenous nitroglycerin.

    Main Methods:

    • Literature review of clinical applications.
    • Discussion of pharmaceutical preparation and stability.

    Main Results:

    • Intravenous nitroglycerin demonstrates utility in improving hemodynamics in left ventricular failure and cardiogenic shock.

    Related Experiment Videos

  • It is effective in controlling hypertension during coronary artery surgery.
  • Potential benefits include reduction of acute myocardial infarct size.

    • Conclusions:

    • Intravenous nitroglycerin is a valuable therapeutic option for several cardiovascular emergencies.
    • Hospital-based extemporaneous preparation is necessary due to the lack of an approved product.
    • Standardization of preparation and storage is crucial for safe and effective use.